<DOC>
	<DOCNO>NCT00829270</DOCNO>
	<brief_summary>Mitochondrial disease frequent metabolic disease ( 2.5 person among 10 000 ) clinically heterogeneous make diagnosis particularly challenging clinician . Molecular analysis mitochondrial DNA ( mtDNA ) critical step diagnosis genetic counsel respiratory chain defect . DNA sequence remains gold standard time-consuming fails detect mutation may present low heteroplasmic level ( 20 % ) ; therefore diagnosis yet base detection number pathogenic mutation . The present study aim evaluate benefit cost diagnosis strategy base combine use 2 technique name `` Surveyor Nuclease '' `` Mitochip '' . Surveyor nuclease mismatch-specific DNA endonuclease use screen entire mtDNA order identify heteroplasmic mutation . In absence identify mutation , another technique base use oligonucleotide sequence microarray ( MitoChip ) perform identification homoplasmic mutation . Mitochip array-based sequence platform rapid high-throughput analysis mitochondrial DNA . The economical study compare cost technique standard diagnosis method term direct indirect cost</brief_summary>
	<brief_title>Economic Medical Evaluation Whole Mitochondrial DNA Screening Surveyor Mitochips Techniques</brief_title>
	<detailed_description />
	<mesh_term>Mitochondrial Diseases</mesh_term>
	<criteria>patient without deletion mitochondrial disease and/or 3243 , 8344 8993 mutation patient health insurance patient deletion mitochondrial disease and/or 3243 , 8344 8993 mutation absence patient consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>